PhoenixBio Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-432	59	510	-393	-223
Depreciation & Amortization	28	25	23	86	55
Loss (Gain) From Sale of Assets	15	1	-	265	-
Loss (Gain) From Sale of Investments	-	-17	-	-	-
Other Operating Activities	23	-41	2	3	28
Change in Accounts Receivable	47	69	-60	-48	54
Change in Inventory	-35	-83	-105	-19	-56
Change in Accounts Payable	-3	-38	14	15	-31
Change in Other Net Operating Assets	284	-54	-107	107	72
Operating Cash Flow	-73	-79	277	16	-101
Operating Cash Flow Growth	-	-	1631.25%	-	-
Capital Expenditures	-21	-31	-7	-6	-181
Sale (Purchase) of Intangibles	-11	-7	-5	-	-1
Investment in Securities	-	144	-136	-	-
Other Investing Activities	5	9	-8	-	-2
Investing Cash Flow	-27	115	-156	-6	-184
Short-Term Debt Issued	-	100	-	-	-
Long-Term Debt Issued	-	400	-	-	-
Total Debt Issued	-	500	-	-	-
Short-Term Debt Repaid	-	-	-	-	-200
Long-Term Debt Repaid	-79	-745	-	-2	-20
Total Debt Repaid	-79	-745	-	-2	-220
Net Debt Issued (Repaid)	-79	-245	-	-2	-220
Issuance of Common Stock	-	37	142	-	84
Other Financing Activities	-49	-36	-56	-32	-24
Financing Cash Flow	-128	-244	86	-34	-160
Foreign Exchange Rate Adjustments	-6	38	22	22	-
Miscellaneous Cash Flow Adjustments	-1	-	-	-	-2
Net Cash Flow	-235	-170	229	-2	-447
Free Cash Flow	-94	-110	270	10	-282
Free Cash Flow Growth	-	-	2600.00%	-	-
Free Cash Flow Margin	-6.10%	-6.41%	12.71%	0.76%	-27.84%
Free Cash Flow Per Share	-23.24	-29.09	53.25	3.03	-87.20
Cash Interest Paid	5	2	3	-	-
Cash Income Tax Paid	-10	49	12	4	2
Levered Free Cash Flow	252.88	-203.13	82.25	-45	-215.75
Unlevered Free Cash Flow	256	-201.88	84.13	-45	-215.13
Change in Working Capital	293	-106	-258	55	39

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.